EIS Organising Committee

Mr. Alistair Laidlaw
President

EURETINA

PROF. RAMIN TADAYONI
PRESIDENT ELECT

EURETINA

Prof. Anat Loewenstein
General Secretary

EURETINA

Prof. Anat Loewenstein
General Secretary

EURETINA

Dr. Kourous Rezaei
Co-opted Board Member

EURETINA

Dr. Kourous Rezaei
Co-opted Board Member

EURETINA

Prof. Frank Holz
Past President

EURETINA

DARA CONLON
EXECUTIVE VICE-PRESIDENT

EURETINA

Contributors

Euretina is delighted to announce the following speakers and panellists confirmed to participate in the Inaugural EURETINA Innovation Spotlight (EIS) taking place on the 4th October 2023 at the RAI Amsterdam, preceding the EURETINA Annual Congress. 

We will be announcing further contributors as they are confirmed.

Ms. Megan Baldwin
Managing Director & CEO

OPTHEA

Mr. Pierre Billardon
CEO

DUTCH OPHTHALMIC RESEARCH CENTRE

Mr. Mikhail Boukhny
Global Head of R&D

BVI

Dr. Christopher Brittain
VP Global Head of Ophthalmology Product Development

GENENTECH

Ms. Anne Marie Cairns
Chief Clinical Officer

OPTOS

Mr. Victor Chong
VP, Global Head of Retina

JANSSEN R&D LLC

Dr. Thomas Ciulla
Chief Medical Advisor – Retina & Chair Scientific Advisory Board

CLEARSIDE BIOMEDICAL

 

Mr. Justin Creel
Head Targeted Therapeutics Delivery

NOVARTIS

Dr. Anupam Dalal
Chief Investment Officer

ACUTA CAPITAL PARTNERS

Mr. Andrew Dick
CEO

CIRRUS

Mr. George Elston
CFO

EYEPOINT PHARMA

Prof. Nicole Eter

UNIVERSITY OF MUNSTER

Mr. Sascha Fauser
Global Head of Ophthalmology

ROCHE

Dr. Laurent Fischer
President & CEO

ADVERUM BIOTECHNOLOGIES

Dr. Cedric Francois
President & CEO

APELLIS PHARMACEUTICALS USA

Dr. Mohamed Genead
Co-Founder, CEO & President

AVICEDA THERAPEUTICS INC. 

 

Ms. Anta Gkelou
Principal Capital Strategy

SOFINNOVA PARTNERS

Dr. Ulrike Graefe-Mody
Global Head Retinal Health

BOEHRINGER INGELHEIM

Mr. Bernhard Guenther
CEO & Chairman of the Board

OPHTHOROBOTICS AG

Mr. Paul Hallen
VP Global Head Retina & Glaucoma

ALCON

Dr. Naama Hammel
Clinical Research Scientist

GOOGLE HEALTH

Mr. Yehia Hashad
EVP of R&D and CMO

BAUSCH + LOMB

Ms. Erin Henry
VP Product Strategy & Innovation

IVERIC BIO AN ASTELLAS COMPANY

Dr. Ralf Hornig
Clinical Affairs Director

PIXIUM VISION SA

Dr. Robert Kim
Chief Medical Officer

4D MOLECULAR THERAPEUTICS

Dr. Sergio Leal
Director, Global Clinical Leader

BAYER

Dr. Stephanie Magazzeni
Head of Digital Research and Innovation

ZEISS

Mr. Antony Mattessich
President & CEO

OCULAR THERAPEUTIX

Dr. Helge Menz
Assistant to the General Manager

PHARMPUR GMBH

Mr. Kester Nahen
CEO

NOTAL VISION

Dr. Grazia Pertile

IRCCS OSPEDALE, SPAIN

Prof. Tunde Peto

QUEENS’ UNIVERSITY BELFAST

Prof. Jose Carlos Pastor Jimeno

UNIVERSITY OF VALLADOLID, SPAIN

Prof. Mario Romano

HUMANITAS UNIVERSITY, MILAN

Dr. Mathias Schifflers
GMA Head of Eyecare

ABBVIE EYECARE

Mr. Ron Schneider
CEO Beyeonics Surgical

BEYEONICS

Ms. Arianna Schoess Vargas
Managing Director

HEIDELBERG ENGINEERING GMBH

DR. Riad Sherif
CEO

OCULIS

Mr. Christoph Spuhler
CEO

ACUSURGICAL

Dr. David Tanzer
Chief Medical Officer

OCUTERRA THERAPEUTICS

Mr. Blaise Thomson
CEO

BITFOUNT

Mr. Ramin Valian
Vice President-US Eye Care

ABBVIE

Mr. Edward Van Wezel
Managing Partner

BIOGENERATION VENTURES

Dr. Kerstin Wickstrom
Expert, Clinical Unit

ICELANDIC MEDICINES AGENCY

DR. Charles Wykoff

HOUSTON METHODIST HOSPITAL & BLANTON EYE INSTITUTE